인쇄하기
취소

BMS Korea is in dilemma over price of new leukemia drug

Published: 2008-05-14 06:59:00
Updated: 2008-05-14 06:59:00
BMS Korea is reportedly in internal discussion over the Ministry for Health, Welfare and Family Affair committee's decision on the price of Sprycel, a new drug for the disease.

On May 7, the committee decided to fix 55,000 won per 70-milligram-pill.

"Our official announcement will be made available after receiving the price notice from the competent authorities," a company official said.
...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.